---
title: 'Metabolomics profiling predicts outcome of tocilizumab in rheumatoid arthritis:
  an exploratory study'
date: '2021-08-16'
linkTitle: http://link.springer.com/10.1007/s11306-021-01822-2
source: Latest Results for Metabolomics
description: ' <h3 class="a-plus-plus">Abstract</h3> <span class="a-plus-plus abstract-section
  id-a-sec1"> <h3 class="a-plus-plus">Introduction</h3> <p class="a-plus-plus">To
  study metabolic signatures can be used to identify predictive biomarkers for a patient''s
  therapeutic response.</p> </span> <span class="a-plus-plus abstract-section id-a-sec2">
  <h3 class="a-plus-plus">Objectives</h3> <p class="a-plus-plus">We hypothesized that
  the characterization of a patients’ metabolic profile, utilizing one-dimensional
  nuclear magnetic resonance (<sup class="a-plus-plus">1</sup>H-NMR), may predict
  a response to ...'
---
 <h3 class="a-plus-plus">Abstract</h3> <span class="a-plus-plus abstract-section id-a-sec1"> <h3 class="a-plus-plus">Introduction</h3> <p class="a-plus-plus">To study metabolic signatures can be used to identify predictive biomarkers for a patient's therapeutic response.</p> </span> <span class="a-plus-plus abstract-section id-a-sec2"> <h3 class="a-plus-plus">Objectives</h3> <p class="a-plus-plus">We hypothesized that the characterization of a patients’ metabolic profile, utilizing one-dimensional nuclear magnetic resonance (<sup class="a-plus-plus">1</sup>H-NMR), may predict a response to ...